Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 3,338 Castle Biosciences, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 17, 2026

On Jun 15, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 3,338 Castle Biosciences, Inc. shares at US$20.66 for US$68,963 under a trading plan, leaving 12,646 shares. Filed Jun 17, 2026 (Form 4).

Sold
3,338 shares
Price
US$20.66
Value
US$68,963
Holding after
12,646 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockOption exercise550US$2.3922,029Direct
Jun 15, 2026Common StockSale550US$20.6621,479Direct
Jun 15, 2026Common StockSale1,357US$20.6642,067Indirect
Jun 15, 2026Common StockSale1,153US$20.6635,755Indirect
Jun 15, 2026Common StockSale278US$20.6612,646Indirect

Source

View original at SEC

Related